Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial

Published:2018-03-12 Issue:3 Volume:67 Page:420-429
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Arenas-Pinto Alejandro¹,Grund Birgit²,Sharma Shweta³,Martinez Esteban⁴,Cummins Nathan⁵,Fox Julie⁶,Klingman Karin L⁷,Sedlacek Dalibor⁸,Collins Simon⁹,Flynn Patricia M¹⁰,Chasanov William M¹¹,Kedem Eynat¹²,Katlama Christine¹³,Sierra-Madero Juan¹⁴,Afonso Claudia¹⁵,Brouwers Pim⁷,Cooper David A¹⁶,

Affiliation:

1. Medical Research Council Clinical Trials Unit, University College London, United Kingdom

2. School of Statistics, Minneapolis

3. Division of Biostatistics, University of Minnesota, Minneapolis

4. Hospital Clinic, Barcelona, Spain

5. Mayo Clinic, Rochester, Minnesota

6. Guy’s and St. Thomas’ NHS Foundation Trust, London, United Kingdom

7. Division of AIDS, National Institute of Allergy & Infectious Diseases, National Institutes of Health, Bethesda, Maryland

8. University Hospital Plzen, Czech Republic

9. HIV i-Base, London, United Kingdom

10. St. Jude Children’s Research Hospital, Memphis, Tennessee

11. Cooper University Hospital, Camden, New Jersey

12. Clinical Immunology Unit, Rambam Health Care Center, Haifa, Israel

13. Hospitalier Pitié-Salpétrière, Paris, France

14. Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Tlalpan, México

15. Hospital de Santa Maria, Lisbon, Portugal

16. The Kirby Institute, University of New South Wales, Sydney, Australia

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/67/3/420/25156337/ciy051.pdf

Reference22 articles.

1. Adoption of national recommendations related to use of antiretroviral therapy before and shortly following the launch of the 2013 WHO consolidated guidelines;Nelson;AIDS,2014

2. Discontinuation of Atripla as first-line therapy in HIV-1 infected individuals;Scourfield;AIDS,2012

3. Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data;Mollan;Ann Intern Med,2014

4. No evidence of an association between efavirenz exposure and suicidality among HIV patients initiating antiretroviral therapy in a retrospective cohort study of real world data;Nkhoma;Medicine (Baltimore),2016

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors associated with suicidal ideation among people with HIV engaged in care;Journal of Affective Disorders;2024-08

2. Self-injurious unnatural death among Veterans with HIV;AIDS;2024-05-28

3. Factors Influencing Co-Morbid Suicidal Ideation among Newly diagnosed HIV/AIDS Patients in Shenzhen: A Structural Equation Model (Preprint);2023-03-02

4. BHIVA guidelines on antiretroviral treatment for adults living with HIV‐1 2022;HIV Medicine;2022-12

5. BAGEL: A Bayesian graphical model for inferring drug effect longitudinally on depression in people with HIV;The Annals of Applied Statistics;2022-03-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3